Back to Search Start Over

Clinical profiles and patterns of kidney disease progression in C3 glomerulopathy

Authors :
Caravaca-Fontán, Fernando
Cavero, Teresa
Díaz-Encarnación, Montserrat M.
Cabello-Chaves, Virginia
Ariceta, Gema
Quintana, Luis F.
Marco, Helena
Barros, Xoana
Ramos, Natalia
Rodríguez-Mendiola, Nuria
Cruz, Sonia
Fernández-Juárez, Gema
Rodríguez, Adela
Pérez de José, Ana
Rabasco, Cristina
Rodado, Raquel
Fernández, Loreto
Pérez Gómez, Vanessa
Ávila, Ana
Bravo, Luis
Espinosa, Natalia
Allende, Natalia
Sánchez de la Nieta, María Dolores
Rodríguez, Eva
Rivas, Begoña
Melgosa, Marta
Huerta, Ana
Miquel, Rosa
Mon, Carmen
Fraga, Gloria
de Lorenzo, Alberto
Draibe, Juliana
González, Fayna
Shabaka, Amir
López-Rubio, María Esperanza
Fenollosa, María Ángeles
Martín-Penagos, L.
Da Silva, Iara
Alonso Titos, Juana
Rodríguez de Córdoba, Santiago
Goicoechea de Jorge, Elena
Praga, Manuel
Instituto de Salud Carlos III
European Commission
Red de Investigación Renal (España)
Comunidad de Madrid
Ministerio de Economía y Competitividad (España)
Caravaca-Fontán, Fernando
Cavero, Teresa
Díaz-Encarnación, Montserrat M.
Ariceta, Gema
Quintana, Luis F.
Barros, Xoana
Ramos, Natalia
Rodríguez-Mendiola, Nuria
Fernández-Juárez, Gema
Pérez de José, Ana
Pérez Gómez, Vanessa
Allende, Natalia
Sánchez de la Nieta, María Dolores
Rivas, Begoña
Melgosa, Marta
Huerta, Ana
Miquel, Rosa
Mon, Carmen
de Lorenzo, Alberto
Draibe, Juliana
González, Fayna
Shabaka, Amir
Martín-Penagos, L.
Rodríguez de Córdoba, Santiago
Goicoechea de Jorge, Elena
Praga, Manuel
Publication Year :
2023
Publisher :
Wolters Kluwer, 2023.

Abstract

14 p.-4 fig.-3 tab.<br />Background C3 glomerulopathy is a rare kidney disease, which makes it difficult to collect large cohorts of patients to better understand its variability. The aims of this study were to describe the clinical profiles and patterns of progression of kidney disease.<br />Methods This was a retrospective, observational cohort study. Patients diagnosed with C3 glomerulopathy between 1995 and 2020 were enrolled. Study population was divided into clinical profiles by combining the following predictors: eGFR under/above 30 ml/min per 1.73 m2, proteinuria under/above 3.5 g/d, and histologic chronicity score under/above 4. The change in eGFR and proteinuria over time was evaluated in a subgroup with consecutive measurements of eGFR and proteinuria.<br />Results One hundred and fifteen patients with a median age of 30 years (interquartile range 19–50) were included. Patients were divided into eight clinical profiles. Kidney survival was significantly higher in patients with a chronicity score<br />Conclusions Kidney survival is significantly higher in patients with a chronicity score<br />Work in this study was supported by the Instituto de Salud Carlos III/Fondo Europeo de Desarrollo Regional (ISCIII/FEDER) grant PI16/01685 and PI19/1624, and Red de Investigación Renal (RedInRen) (RD12/0021/0029) (to MP), the Autonomous Region of Madrid (S2017/BMD-3673) (to MP). SRdeC is supported by Ministerio de Economia y Competitividad grant PID2019-104912RB-I00 y Autonomous Region of Madrid grant S2017/BMD-3673.

Details

Language :
English
ISSN :
20191049
Database :
OpenAIRE
Accession number :
edsair.od......1106..b5e8b2025ab1ca95b8c0b3c144194a40